| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 9.627 | 18.451 | 29.663 | 39.816 | 31.748 | 15.333 | 41.425 | 92.164 | 114.890 | 101.422 |
| Total Income - EUR | 9.628 | 18.451 | 29.663 | 39.816 | 31.748 | 15.333 | 41.425 | 92.164 | 114.890 | 101.422 |
| Total Expenses - EUR | 2.469 | 9.148 | 10.044 | 25.821 | 30.225 | 29.341 | 35.845 | 74.481 | 104.742 | 84.582 |
| Gross Profit/Loss - EUR | 7.159 | 9.303 | 19.619 | 13.995 | 1.523 | -14.007 | 5.580 | 17.683 | 10.147 | 16.840 |
| Net Profit/Loss - EUR | 6.870 | 8.749 | 16.449 | 13.596 | 1.205 | -14.159 | 5.166 | 16.759 | 8.998 | 13.797 |
| Employees | 2 | 3 | 3 | 4 | 2 | 4 | 3 | 4 | 4 | 3 |
Check the financial reports for the company - Ultrasun Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 2.898 | 40.063 | 48.877 | 41.002 | 36.749 | 29.650 | 22.082 | 23.021 | 12.828 | 38.734 |
| Current Assets | 3.073 | 1.128 | 15.786 | 49.278 | 38.644 | 13.558 | 6.816 | 5.889 | 12.456 | 17.766 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 489 | 3.395 | 8.065 | 956 |
| Receivables | 30 | 30 | 29 | 60 | 51 | 58 | 150 | 217 | 379 | 6.352 |
| Cash | 3.043 | 1.098 | 15.757 | 49.219 | 38.593 | 13.500 | 6.178 | 2.277 | 4.013 | 10.458 |
| Shareholders Funds | -5.439 | 3.366 | 19.758 | 29.795 | 1.256 | -12.927 | -7.475 | 9.260 | 11.909 | 13.846 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 11.409 | 37.824 | 44.904 | 60.485 | 74.306 | 56.136 | 36.373 | 19.649 | 13.376 | 42.654 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Ultrasun Med S.r.l.